COSM
Cosmos Health Inc.
COSM lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
COSM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Weak |
COSM's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
COSM PE Valuation
COSM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 2.1x next year's earnings.
COSM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect COSM to return to profit, with revenue growing. However, they disagree widely on these estimates.
COSM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.10 | — |
| Q2 2026 | -$0.66 | +$0.38 |
| Q1 2026 | -$0.66 | +$0.43 |
| Q4 2025 | -$0.63 | +$0.54 |
| Q3 2025 | -$0.76 | +$1.70 |
| Q2 2025 | -$1.04 | +$1.24 |
| Q1 2025 | -$1.09 | +$1.13 |
| Q4 2024 | -$1.17 | +$0.98 |
| Q3 2021 | -$11.50 | -454% |
COSM is still losing money, but far less than before: $0.66 per share over the past year, against $25.00 at its worst in late 2019.
COSM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19M | +29% |
| Q1 2026 | $17.9M | +31% |
| Q4 2025 | $19.7M | +39% |
| Q3 2025 | $17.1M | +38% |
| Q2 2025 | $14.7M | +12% |
| Q1 2025 | $13.7M | -6% |
| Q4 2024 | $14.2M | -10% |
| Q3 2024 | $12.4M | -3.2% |
COSM's revenue has grown year over year for five quarters in a row: $19M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -15% | +2.5 points |
| Q1 2026 | -12% | -6.1 points |
| Q4 2025 | -58% | +5.1 points |
| Q3 2025 | -11% | +7.4 points |
| Q2 2025 | -18% | +1 points |
| Q1 2025 | -6.1% | +6.5 points |
| Q4 2024 | -63% | +23 points |
| Q3 2024 | -18% | +5.5 points |
COSM's operating margin was −15% last quarter, up 2.5 points from the same quarter a year ago.
COSM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | -$549.4K |
| Q1 2026 | -$1.1M | -$879.6K |
| Q4 2025 | -$4.6M | -$697.9K |
| Q3 2025 | -$2.5M | -583% |
| Q2 2025 | -$1.2M | +$12.6K |
| Q1 2025 | -$198.8K | +$3.3M |
| Q4 2024 | -$3.9M | -532% |
| Q3 2024 | $511K | +$5.1M |
COSM has burned cash in almost every quarter: −$10M over the past year, against −$5M the year before.
COSM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | 8.5x | High |
| Q4 2020 | 3.3x | Elevated |
| Q3 2020 | -0.3x | Net Cash |
| Q2 2020 | -1.1x | Net Cash |
| Q1 2020 | -1.9x | Net Cash |
| Q4 2019 | 0.6x | Very low |
COSM's net debt is about 8.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
COSM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 31.7 | Neutral |
COSM's weekly RSI is 41 (neutral) and its Stochastic is 32 (neutral).
COSM PE vs Healthcare Sector
| Metric | COSM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
COSM has no meaningful PE right now: it lost money over the past year.
COSM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.31 | 32% below |
| 20 week MA | $0.27 | 22% below |
| 50 week MA | $0.33 | 36% below |
| 100 week MA | $0.49 | 57% below |
| 200 week MA | $1.10 | 81% below |
COSM is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
COSM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $127.5 | +104% |
| 2021 | $127.5 | $99.0 | -22% |
| 2022 | $99.0 | $6.40 | -94% |
| 2023 | $6.40 | $1.41 | -78% |
| 2024 | $1.41 | $0.68 | -52% |
| 2025 | $0.68 | $0.51 | -25% |
| 2026 YTD | $0.51 | $0.21 | -59% |
COSM has finished five years in a row lower, and it's down 59% so far in 2026.